Sharad Yadav admitted to AIIMS post complaints of chest pain

Published On 2015-07-03 11:32 GMT   |   Update On 2015-07-03 11:32 GMT

 Sharad Yadav now undergoing treatment for lung infectionThe JD(U) minister, Sharad Yadav, is being treated in All India Institute of Medical Sciences (AIIMS) in New Delhi for the past 15 days. He was received at the hospital in a state of a nagging chest pain and other complications, which had initially affected his (Sharad Yadav’s) health.The minister is currently undergoing a treatment...

Login or Register to read the full article
 Sharad Yadav now undergoing treatment for lung infection

The JD(U) minister, Sharad Yadav, is being treated in All India Institute of Medical Sciences (AIIMS) in New Delhi for the past 15 days. He was received at the hospital in a state of a nagging chest pain and other complications, which had initially affected his (Sharad Yadav’s) health.

The minister is currently undergoing a treatment for lung infection, and is stated to be out of danger now. He might be discharged soon, as per a recent press statement.

As per the details shared by PTI,

He was admitted to AIIMS on June 22 after he complained of chest pain and other complications.

Though it is around a fortnight since he has been admitted to the hospital, sources close to him said he is now out of danger and is likely to be discharged soon.

"Sharad ji has recovered and is recuperating fast," they said.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News